Skip to main content
. 2014 Jan 23;9(4):698–704. doi: 10.2215/CJN.08160813

Figure 3.

Figure 3.

Measurements of circulatory endothelial and endothelial surface layer damage markers in participants with and without loss of renal function. Markers were measured in healthy controls (n=10) and patients with ESRD (n=23), stable KTx (n=12), and IFTA (n=10). (A) Serum angiopoietin-2 (Ang2). (B) Serum soluble thrombomodulin (sTM). (C) Plasma shed syndecan-1. Box plot whiskers indicate 1st and 99th percentiles. *P<0.05; **P<0.01; **P<0.001.